It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2022.
2022 | Ahmedabad, Gujarat, India | ActiveAneta Pharmaceuticals Private Limited, a active private limited company, was established on 04 May 2022 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2022PTC131644. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹4.50 Cr.
Employing 188 professional, Its leadership includes Nitin Jasvantbhai Patel (Director), Rameshbhai Khimjibhai Patel (Director), Subhash Jayantibhai Chhabhaiya (Director). Past directors included Rameshbhai Khimjibhai Patel. It holds ₹34.93 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 808, Shilp Zaveri, Shyamal Cross Road Satelite, Ahmedabad, Gujarat, 380015.
U24230GJ2022PTC131644
131644
04 May 2022
₹4.50 Cr
₹4.50 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Aneta Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Jasvantbhai Patel | Director | 04 May 2022 | Current |
| Rameshbhai Khimjibhai Patel | Director | 18 Aug 2022 | Current |
| Subhash Jayantibhai Chhabhaiya | Director | 04 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aneta Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 174.28% increase. The company also saw a substantial fall in profitability, with a 11527.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 141.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Aneta Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹349,346,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2024 | Hdfc Bank Limited | ₹1.85 M | Open |
| 30 Sep 2022 | Hdfc Bank Limited | ₹34.75 Cr | Open |
Explore comprehensive loan charge details -
Aneta Pharmaceuticals has a workforce of 188 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aneta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aneta Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aneta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 34.75 Cr registered on 30 Sep 2022 with Charge ID 100624900 was modified on 24 Jul 2025. was recorded as a recent event.
Progress on Aneta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100848483 was registered on 04 Jan 2024. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 34.75 Cr with Charge ID 100624900 was registered on 30 Sep 2022. was completed.
The activity Rameshbhai Khimjibhai Patel was appointed as a Director was appointed as a Director on 18 Aug 2022 & has been associated with this company since 3 years 3 months . was completed.
The CIN of Aneta Pharmaceuticals Private Limited is U24230GJ2022PTC131644.
Aneta Pharmaceuticals Private Limited is headquartered at 808, Shilp Zaveri, Shyamal Cross Road Satelite, Ahmedabad, Gujarat, 380015.
Aneta Pharmaceuticals Private Limited was incorporated on 04 May 2022.
The current directors of Aneta Pharmaceuticals Private Limited are
The primary industry of Aneta Pharmaceuticals Private Limited is Manufacturing.
Aneta Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aneta Pharmaceuticals Private Limited is ₹4.50 Cr, and the paid-up capital is ₹4.50 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX